Table 3.

Target prediction and pathway enrichment analysis of hsa-miR-145-5p.

Gene Symbol	Gene Description	miRANDA	miRDB	TargetScan
ABCE1	ATP-binding cassette, sub-family E, member 1	−2.33	100	−0.73
ADD3	adducin 3	−1.59	98	−0.61
ATXN2	ataxin 2	−2	97	−0.54
DAB2	disabled homolog 2, mitogen-responsive phosphoprotein	−2.71	100	−0.62
EPS15	epidermal growth factor receptor pathway substrate 15	−1.55	87	−0.3
EXOC8	exocyst complex component 8	−1.89	93	−0.6
FSCN1	fascin homolog 1, actin-bundling protein	−1.97	97	−0.97
LOX	lysyl oxidase	−2.24	97	−0.34
MPZL2	myelin protein zero-like 2	−2.36	100	−0.61
NAV3	neuron navigator 3	−1.99	95	−0.74
SEMA3A	sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3 A	−1.9	99	−0.65
ST6GALNAC3	ST6(alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3	−1.87	98	−0.61
TMEM9B	TMEM9 domain family, member B	−1.72	85	−0.62
YTHDF2	YTH domain family, member 2	−2.3	99	−0.64

In silico analysis predicted 14 target mRNAs for hsa-miR-145-5p.